الصحافة والإعلام
News Center
اطّلع على آخر أخبار RudaCure وبياناتها الصحفية.
RudaCure Magazine
Our quarterly magazine covering the latest research progress and company updates. Available for free PDF download.
Company2026-07-04
RudaCure showcases dry eye and pain pipeline competitiveness at BIO USA 2026
Company2026-07-04
RudaCure Holds Partnering Meetings with 27 Teams at InterBiz 2026
Company2026-06-23
RudaCure Runs On-Site Booth at BIO USA 2026, Ramping Up Global Partnering
Company2026-06-18
RudaCure to Present at BIO USA 2026 — Showcasing Membrane Protein-Targeted Pipeline for Dry Eye, Pain & Psoriasis
Company2026-06-09
RudaCure participates in BIO USA 2026 and delivers Company Presentation
Company2025-10-15
2025 Pain Therapeutics Summit 참석
Company2025-08-11
[Interview] RudaCure focuses on root causes of pain — developing side-effect-free chronic pain and dry eye treatments
Company2025-07-21
RudaCure holds 7th anniversary celebration ceremony
Company2025-07-12
2025 H1 performance review and H2 goal-setting workshop successfully completed
Company2025-06-12
RudaCure pursues global partnering for RCI001/RCI002 and gene therapy co-development at 2025 BIO-USA
Company2025-05-12
RudaCure conducts plogging and blood donation campaign in Gwangmyeong on Culture Day
Company2025-05-09
2025 Bio-Korea 참석
Company2025-04-30
Culture Day event: Anyang Stream plogging and Gwangmyeong blood donation
Company2025-04-10
Attendance at DEALMAKER ACADEMY global bio-partnering seminar
Company2025-03-27
Attendance at 2025 Bio-Europe Spring and Ceva visit in France
Company2025-02-13
POSTECH Prof. Dohun Kwon seminar on TRPV1 structural analysis
Company2024-12-16
RudaCure develops dry eye treatment with reduced drug exposure period [Core Innovation Korea 2024]
Company2024-10-23
Efficacy of RCI001 as a Therapeutic Candidate in a Primary Sjögren Syndrome Mouse Model
Company2024-06-07
RudaCure Inc. attends global bio expo BIO USA 2024
Company2024-06-01
Efficacy of RCI001 as a therapeutic candidate of dry eye disease in a modified mixed dry eye model
Company2024-05-20
Global biopharmaceutical company RudaCure puts ESG management into full practice in line with the latest management trends
Company2024-05-09
Incheon Free Economic Zone Agency operates IFEZ bio-health supply chain special pavilion at BIO KOREA 2024
Company2024-04-03
IBK Innovation Hub Europe accelerator program — 8 promising startups head to Europe
Company2024-03-15
6th Annual General Shareholders' Meeting
Company2024-03-14
Visit to France's Ceva for RCI001AH joint research
Company2024-01-08
2024 RudaCure New Year Ceremony
Company2023-11-14
Korea Health Industry Development Institute supports 38 companies at Bio Europe 2023
Company2023-11-14
[Cover Story] Key targets and development hurdles for non-narcotic analgesics
Company2023-11-02
KICDC/Defy Pitch Competition Final Round Prize
Company2023-10-18
Prof. Kim Dong-hyun at Anam Hospital demonstrates long-term safety of RCI001
Company2023-10-11
Global Innovation Roadshow in Singapore
Company2023-10-09
Comparison of RCI001 and corticosteroid on the effects on intraocular pressure in mice
Company2023-10-06
Attendance at The University of Utah Asia Campus event
Company2023-07-14
Comparison of Corneal Epithelial Wound Healing between Topical RCI001, Solcoseryl, and Polydeoxyribo
Company2023-05-04
IP listing specialist Darae Strategic Commercialization Center joins forces with pain drug developer RudaCure Inc.
Company2023-03-28
Bio-venture RudaCure joins hands with veterinary drug leaders Onhil and Onhil Pet for animal drug development
Company2023-03-21
2023 Bio-EU Partnering Meeting in progress
Company2023-03-14
5th Annual General Shareholders' Meeting convened
Company2023-02-10
Technology-armed K-BIO ventures hit consecutive jackpots
Company2023-01-20
Songdo Bio Complex — a matured commercialization-focused bio cluster
Company2023-01-16
Incheon Free Economic Zone supports startup product/service early commercialization
Company2022-12-01
CDISC adoption in pharma-bio industry: a necessity, not an option
Company2022-11-29
[2022 BigWave Startup CEO] RudaCure — a startup developing eye disease and chronic pain treatments
Company2022-11-28
[Bio-health startup support platform fostering unicorn companies worth KRW 1T]
Company2022-10-28
Journal of Ocular Pharmacology and TherapeuticsOcular Distribution and Pharmacokinetics of8-Oxo-2′-Deoxyguanosine:A Novel Therapeutic Candidate of Ocular Surface Diseases
Company2022-09-30
Innovator’s Pitch Challenge Winners at RESI Boston[LIFE SCIENCE NATION NEXT PHASE NEWSLETTER]
Company2022-09-29
Non-narcotic analgesics take center stage — domestic development race heats up
Company2022-09-26
RESI Innovator's Pitch Challenge — 3rd place
Company2022-09-16
2022 Shareholders' Meeting
Company2022-09-15
Attending 2022 RESI Conference
Company2022-08-14
UKC2022 참석
Company2022-08-14
Seoul office relocation completed
Company2022-08-08
The Bell: Unlisted pharma-bio funding review — small molecule + inhibitor funding tops
Company2022-06-28
RudaCure plans H2 domestic Phase 1 for Rac1 inhibitor dry eye treatment
Company2022-06-16
RudaCure: overcoming steroid limitations with dry eye drug RCI001
Company2022-06-08
First in-person BIO-USA in 3 years — K-Bio unveils post-COVID strategy
Company2022-06-08
Korea Bio Association operates Korean pavilion at 2022 BIO-USA
Company2022-06-07
Innovative dry eye drug compound RCI001 draws renewed attention
Company2022-05-30
IFEZ introduction video: RudaCure — dry eye treatment developer
Company2022-05-20
Woongbi launches FLIPR-based service with Molecular Devices
Company2022-04-19
Breaking into the global pharmaceutical market
Company2022-03-24
Investigating the Anti-Inflammatory Effects of RCI001 for Treating Ocular Surface Diseases: Insight
Company2022-03-11
ARVO 2022 Poster Presentation
Company2022-02-21
[Doctor Startup] Embracing even the pain — a story of passion
Company2022-02-16
Bio startups take on US market challenge — launched at KIC Washington
Company2022-02-16
Comparison of therapeutic effects between topical 8-oxo-2'-deoxyguanosine and corticosteroid in ocul
Company2022-02-11
Biospectator: RudaCure discovers TRPV1-targeting analgesic — avoiding hyperthermia
Company2022-02-10
2022 JPM conference meetings successfully concluded
Company2021-12-30
K-Bio ventures pursue global drug development — notable companies and differentiators in 2021
Company2021-12-30
Pharmaceutical companies line up to develop dry eye treatments
Company2021-12-06
MOTIE R&D Rediscovery project completed
Company2021-10-14
BMC: Improved accuracy of intraocular lens power calculation by preoperative management of dry eye d
Company2021-10-10
Startup Spotlight: Getting to know RudaCure!
Company2021-09-06
Prime Minister Kim Bu-gyeom visits Korea's first Incheon Startup Park
Company2021-08-19
RudaCure U.S.A. Inc 설립
Company2021-08-05
TRPV1-targeting pharmaceutical composition European patent application completed
Company2021-07-16
Who will be the future unicorn? Incheon Startup Park builds the path
Company2021-07-03
Minister Moon pledges support for Songdo bio-cluster — attends bio-company roundtable
Company2021-06-11
BioKorea2021 참석
Company2021-05-29
Patent No. 10-2019-0083683: Method for enhancing stem cell migration to cancer cells
Company2021-05-24
From dry eye to pain — developing treatments for quality-of-life sensory disorders
Company2021-05-18
[Incheon Startup Park Rising Stars] (9) RudaCure
Company2021-04-21
Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Us
Company2021-04-20
Green light for domestic dry eye innovation drug — RCI001 more effective than steroids with fewer side effects (Nature Scientific Reports)
Company2021-04-16
2021 ARVO Presentation(Open May 1st)
Company2021-03-17
Headquarters address changed following relocation to Incheon Startup Park
Company2020-12-24
PCT application filed for TRPV1-targeting pharmaceutical composition
Company2020-12-12
Drug success rate 1 in 10,000 — bio-venture challenge continues (Herald Economy)
Company2020-07-31
Now a must-ask when joining SMEs: do they offer government vacation subsidies?
Company2020-07-27
[Special Feature] IFEZ growth strategy — from bio-cluster to Songdo's new bio nest
Company2020-06-10
Hankook Kyungjae: RudaCure's challenge — pain relief through protein genes (20x more effective, no tolerance/addiction)
Company2020-04-22
Metimedi, RudaCure, Voronoi go all-in on COVID-19 and new drug R&D
Company2020-02-07
8-oxo-deoxyguanosine pharmaceutical composition for corneal damage treatment
Company2020-02-07
Opening a new era in pain and eye disease drug research
Company2019-12-13
Bundang CHA Hospital and RudaCure co-develop spine regeneration therapy
Company2019-12-13
RudaCure EVP Han In-bo receives Minister of Health and Welfare commendation
Company2019-12-13